PFO
CC icon

Pathstone Family Office’s Chemours CC Stock Holding History

Pathstone Family Office’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$497K Buy
+17,710
New +$608K ﹤0.01% 1037

Other funds holding CC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Pathstone Family Office's CC Position: Q3 2023 in Review

Pathstone Family Office opened a new position in Chemours (CC) in Q3 2023: 17,710 shares worth $497K. The stake represents ﹤0.01% of the portfolio and ranks #1037 among its holdings.

455 funds tracked by Wall St. Rank hold CC as of Q3 2023.

  • Pathstone Family Office held 17,710 shares of Chemours worth $497K as of Q3 2023.
  • Chemours was a new Pathstone Family Office position in Q3 2023.
  • Chemours made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1037 holding.
  • 455 funds tracked by Wall St. Rank held Chemours as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.